2. Osato MS,Jensen HG, Trousdale MD, et al. The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates. Am J Ophthalmol. 1989;108:380-386.
3.
3. Cekic O, Batman C, Totan Y, et al. Aqueous humor levels of topically applied ciprofloxacin and ofloxacin in the same subjects. Eye. 1999;13:656-659.
4.
4. Foulks GN, Gordon JS, Kowalski RP. Bacterial infections of the conjunctiva and cornea. In: Albert DM, Jakobiec FA, Azar DT, Graroudas ES, eds. Principles and Practice of Ophthalmology, 2nd ed.Philadelphia: WB Saunders; 2000:893-905.
5.
5. Schaad UB. Use of the quinolones in pediatrics. Drugs. 1993;45:37-41.
6.
6. Alghasham AA, Nahata MC. Clinical use of fluoroquinolones in children. Ann Pharmacother2000;34:347-359.
7.
7. Borrmann L, Tang-Liu DD, Kann J, et al. Ofloxacin in human serum, urine, and tear film after topical application. Cornea. 1992;11:226-230.
8.
8. Ross DL, Riley CM. Aqueous solubilities of some variously substituted quinolone antimicrobials. Int J Pharm. 1990;63:237-250.
9.
9. Robert P-Y, Adenis J-P. Comparative review of topical ophthalmic antibacterial preparations. Drugs. 2001;61:175-185.
10.
10. Wilson FM. Adverse external ocular effects of topical ophthalmic medications. Surv Ophthalmol. 1979;24: 57-88.